Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Central Drug Standard Control Organization (CDSCO) of India is set to conduct inspection of drug manufacturing firms in China that import medicines to India.
Subscribe to our email newsletter
The manufacturing units including Southwest Synthetic Pharma Company, Intec Product, Suzhoudawn Ray’s Pharma and Hisoanchuannan Pharma Company will be inspected by the Indian officials.
The cancellation of many import licenses owing to poor drug quality and non-compliance with Good Manufacturing Practices (GMP) has led the organization to make the decision.
In addition, sub standard diagnostic kits are said to have entered the Indian territory.
The inspection will be carried with the consent of Chinese Food and Drug Authority (FDA).